scholarly journals Biochemical changes in lens, aqueous humor and vitreous body and effects of aldose reductase inhibitor (TAT) on rats with experimental diabetes.

1995 ◽  
Vol 62 (4) ◽  
pp. 339-350 ◽  
Author(s):  
Hitoko Saito
Keyword(s):  
Aqueous Humor ◽  
Aldose Reductase ◽  
Reductase Inhibitor ◽  
Experimental Diabetes ◽  
Vitreous Body ◽  
Aldose Reductase Inhibitor ◽  
Biochemical Changes

The Prevention of Biochemical Changes in Lens, Retina, and Nerve of Galactosemic Dogs by the Aldose Reductase Inhibitor AL01576

1989 ◽  
Vol 5 (3) ◽  
pp. 233-240 ◽  
Author(s):  
MARJORIE F. LOU ◽  
JAIME E. DICKERSON ◽  
MICHAEL L. CHANDLER ◽  
R. KIM BRAZZELL ◽  
BILLIE M. YORK
Keyword(s):  
Aldose Reductase ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Biochemical Changes

Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes

1994 ◽  
Vol 48 (5) ◽  
pp. 1003-1008 ◽  
Author(s):  
Jean Pierre Kassab ◽  
Raymonde Guillot ◽  
Jocelyne Andre ◽  
Nicole Claperon ◽  
Georges Bellon ◽  
...  
Keyword(s):  
Aldose Reductase ◽  
Reductase Inhibitor ◽  
Experimental Diabetes ◽  
Aldose Reductase Inhibitor

Studies on peripheral nerve and lens in long-term experimental diabetes: Effects of the aldose reductase inhibitor statil

Metabolism ◽  
1988 ◽  
Vol 37 (5) ◽  
pp. 442-449 ◽  
Author(s):  
G.B. Willars ◽  
J. Townsend ◽  
D.R. Tomlinson ◽  
A.M. Compton ◽  
R.D. Churchill
Keyword(s):  
Peripheral Nerve ◽  
Aldose Reductase ◽  
Reductase Inhibitor ◽  
Experimental Diabetes ◽  
Aldose Reductase Inhibitor

186-OR: Safety and Tolerability of the Next Generation Aldose Reductase Inhibitor (ARI) AT-001 Supports Initiation of the Pivotal Trial in Diabetic Cardiomyopathy (DbCM)

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 186-OR
Author(s):  
RICCARDO PERFETTI ◽  
FRANCESCA C. LAWSON ◽  
JULIO ROSENSTOCK ◽  
JAMES JANUZZI ◽  
SHOSHANA SHENDELMAN ◽  
...  
Keyword(s):  
Aldose Reductase ◽  
Diabetic Cardiomyopathy ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Pivotal Trial ◽  
Next Generation

462-P: AT-001, a Next Generation Aldose Reductase Inhibitor with Improved Selectivity and Specificity, Protects from Cellular Damage Associated with Hyperglycemia

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 462-P
Author(s):  
RICCARDO PERFETTI ◽  
GAUTHAM YEPURI ◽  
NOSIRUDEEN A. QUADRI ◽  
RAVICHANDRAN RAMASAMY ◽  
AMEEN F. GHANNAM ◽  
...  
Keyword(s):  
Aldose Reductase ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Cellular Damage ◽  
Next Generation
Sign in / Sign up

Export Citation Format

Share Document